October 8, 2014

Manufacturers should step up their monitoring of consumer healthcare choices under Obamacare

The Medicare Part D switchover of 2007 is only a partial proxy for what the healthcare system will experience in the next several years.
“Healthcare Exchanges’ Impact on Branded and Generic Manufacturers: the Good, Bad and Unknown”, was the title of a presentation by Tracy Foster, (Lash Group president) at AmerisourceBergen’s ThinkLive manufacturer summit held October 7-8 in Dallas. Pharmaceutical Commerce interviewed Tracy following the conference for her insight on health exchanges and their impact on patient access.